Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $35.30 USD
Change Today -0.18 / -0.51%
Volume 111.3K
MASI On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 12:16 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

52 Discovery

Irvine, CA 92618

United States

Phone: 949-297-7000

Fax:

er (MS-2040) technology in a reduced size, allowing it to be embedded into patient cables as part of the sensor connector. This allows for the ability to interface the uSpO2 cable/board to monitoring devices externally via an existing communications port in instances where internal integration of a traditional Masimo SET technology board is not feasible. The uSpO2 cable/board provides full Masimo SET Measure-Through-Motion and Low-Perfusion pulse oximetry found in the company’s other products, with a typical power consumption of approximately 45 milliwatts. Monitors/Devices Radical-7: The Radical-7 incorporates the company’s MX circuit board, which enables rainbow SET measurements, and offers three-in-one capability that can be used as a standalone device for bedside monitoring; a detachable, battery-operated handheld unit for portable monitoring; and a monitor interface via SatShare, a proprietary technology allowing its products to work with certain competitor products, to upgrade existing conventional multiparameter patient monitors to Masimo SET while displaying rainbow measurements on the Radical-7 itself. The Radical-7 is a wireless, touch screen device, which is on an upgradeable rainbow SET platform. Root: Root is a patient monitoring and connectivity platform that integrates the company’s breakthrough rainbow and SET measurements with multiple additional specialty measurements through Masimo Open Connect (MOC-9) in an integrated, clinician-centric platform. The first two MOC-9 technologies for Root were SedLine brain function monitoring and Phasein capnography. The company’s third MOC-9 technology for Root, O3 regional oximetry, provides for continuous and simultaneous measurement of tissue oxygen saturation (rSo2) and SpO2 to help detect regional hypoxemia that pulse oximetry alone can miss. In addition, Iris connectivity in Root enables 3rd party devices, such as intravenous pumps and ventilators to connect through Root and enables display, notification and documentation to the electronic medical record through Masimo Patient SafetyNet. In 2014, the company announced the U.S. Food and Drug Administration (FDA) clearance for the company’s Root platform with capnography, wireless communication and Iris connectivity for third-party medical devices. O3 regional oximetry has received the CE Mark. In combination with a Radical-7 handheld monitor, Root would display alarm information simplifying patient care workflows and potentially helping caregivers make quicker patient assessments. Radius-7: In 2014, the company announced CE Mark clearance and limited market release of Radius-7 for the Root patient monitoring and connectivity platform. Radius-7 for the Root is the first and only wearable, wireless monitor with the company’s rainbow SET technology, enabling early identification of clinical deterioration while offering patients continuous monitoring with freedom of movement. With rainbow SET noninvasive measurements, Radius-7 with Root can alert clinicians at the bedside or remotely, through Masimo Patient SafetyNet, of critical changes in a patient’s oxygen saturation and pulse rate, even during states of motion and low perfusion, as well as respiration through RRa. Radius-7 with Root obtained FDA 510(k) clearance in December 2014. SatShare: The company’s SatShare technology enables a conventional monitor to receive continuous measurement updates using Masimo SET through a cable connection from the back of Radical-7 to the sensor input port of the conventional monitor. SatShare allows hospitals to standardize the technology and sensors used throughout the hospital. This technology has facilitated many hospital-wide conversions of previously installed competitor monitors to Masimo SET. In addition, Masimo rainbow SET measurements, such as hemoglobin are available to clinicians on the Radical-7 itself while the device is being used in SatShare mode. Pronto: The Pronto is a handheld noninvasive multiparameter testing device that uses Masimo rainbow SET technology to provide oxygen saturation, pulse rate, PI and spot-checking of hemoglobin levels for both hospitals (i.e., emergency departments) and

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MASI:US $35.30 USD -0.18

MASI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CONMED Corp $55.67 USD -0.16
Cyberonics Inc $64.00 USD -0.15
ICU Medical Inc $96.61 USD -0.57
NuVasive Inc $50.63 USD +1.01
Thoratec Corp $45.25 USD -0.52
View Industry Companies
 

Industry Analysis

MASI

Industry Average

Valuation MASI Industry Range
Price/Earnings 27.8x
Price/Sales 3.2x
Price/Book 5.8x
Price/Cash Flow 26.6x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MASIMO CORP, please visit www.masimo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.